The respiratory epithelium plays a major role in the primary defense of the airways against infection. It has been demonstrated that bacterial products are involved in the induction of inflammatory reactions of the upper airways. Little is known about the effects of bacterial products on expression of the antimicrobial peptide hCAP-18/LL-37, the only human cathelicidin identified so far. The aim of this study was to investigate the effects of bacterial products from both gram-positive and gram-negative bacteria on the expression of hCAP-18/LL-37 by sinus epithelial cells using an air-exposed tissue culture model. Lipopolysaccharide and lipoteichoic acid both increased hCAP-18/LL-37 expression in cultured sinus epithelium as assessed by immunohistochemistry, where maximal stimulation occurred at 100 ng ml À1 lipopolysaccharide or 10 lg ml À1 lipoteichoic acid. The stimulatory effect of lipopolysaccharide and lipoteichoic acid was not restricted to expression of hCAP-18/LL-37, since also mucin expression and IL-8 release from cultured sinus epithelium cells were increased by lipopolysaccharide and lipoteichoic acid. This suggests that bacterial products may stimulate innate immunity in the upper airways.
Introduction
The respiratory epithelium provides a major barrier between the body and the environment. However, epithelial cells not only serve as a physical barrier, but also actively participate in the maintenance, renewal and defense of mucosal surfaces by producing various mediators including antimicrobial peptides and proteins [1] . Several antimicrobial peptides and proteins have been identified in airway surface fluid, including lysozyme, lactoferrin, defensins and cathelicidins [2] . Defensins and cathelicidins are antimicrobial peptides produced by leukocytes and epithelial cells and display antimicrobial activity against a broad spectrum of bacteria, fungi and enveloped viruses in vitro [1] . The only human member of the cathelicidin family identified so far is LL-37, the C-terminal part of the human cationic antimicrobial protein 18 (hCAP-18) [3] . Expression of hCAP-18/LL-37 was first shown in neutrophils, where it is stored in the specific granules [4] . Subsequently, hCAP-18/LL-37 expression was demonstrated in monocytes, T-cells [5] , various squamous epithelia [6] and keratinocytes in inflamed skin [7] . In the airways, hCAP-18/LL-37 expression was shown in the surface epithelia of the conducting airways, in the submucosal glands [8] and in the bronchoalveolar lavage fluid [9] . In addition to its antimicrobial activity, LL-37 has been demonstrated to display a variety of other functions; including lipopolysaccharide neutralization [10] ; chemotaxis of neutrophils, monocytes, T-cells [11] and mast cells [12] ; and activation of airway epithelial cells [13, 14] and dendritic cells [15] . Several studies have suggested an important role for LL-37 in vivo. Bals et al. [16] showed that gene transfer of hCAP-18/LL-37 in a cystic fibrosis xenograft model restored bacterial killing to normal levels, suggesting that antimicrobial peptides protect against bacterial infection in vivo. Furthermore, mice deficient in the LL-37 homolog cathelicidin-related antimicrobial peptide (CRAMP) have a decreased capacity to control skin infections [17] . Moreover, deficiency of LL-37 in saliva correlates with the occurrence of periodontal disease in patients with severe congenital neutropenia [18] .
Epithelial expression of antimicrobial peptides can be either constitutive or induced. A variety of studies have shown that microorganisms increase the expression of antimicrobial peptides such as b-defensins [19, 20] and hCAP-18/LL37 [21] . In the case of Shigella spp. infections, expression of LL-37 and b-defensin-1 is reduced or turned off [22] . Besides increasing or decreasing the expression of antimicrobial peptides, microorganisms also activate other components of the host defense system. Many studies have shown that microorganisms increase the expression of pro-inflammatory chemokines such as IL-8, which may result in the recruitment of phagocytes to the site of infection. Furthermore, bacterial products can increase mucus production [23] and mucus hypersecretion is often found in sinusitis [24] . Whereas this increased mucus production may serve as a normal defense mechanism of the upper respiratory tract, hypersecretion may seriously hamper the mucociliary clearance due to changed rheologic properties of the sinus fluid [25] .
Microbial components that have been identified as direct activators of epithelial cells include the lipopolysaccharide (LPS) from gram-negative bacteria and the gram-positive bacterial product lipoteichoic acid (LTA). It has previously been demonstrated that both LPS and LTA increase cytokine, chemokine and mucus production in middle ear epithelial cells [26, 27] . The aim of this study was to investigate the effects of LPS and LTA on human cathelicidin hCAP-18/LL-37 expression in airexposed cultured human sinus epithelial cells. In addition, the effects of LPS and LTA on mucin expression and IL-8 release by sinus epithelial cells was determined.
Materials and methods

Tissues
Samples of healthy respiratory sinus epithelium were taken from normal sphenoidal sinuses during transsphenoidal pituitary surgery of 10 patients. These patients suffered from a pituitary-adenoma and transsphenoidal extirpation of their pituitary gland. During surgery the sphenoid is normally discarded and could therefore be used anonymously for these experiments. The patients never suffered from sinusitis and did not receive radiation or medication prior to surgery that could have influenced the sphenoid epithelium. Sphenoid tissue was used as source of healthy ciliated mucosa for in vitro experiments.
Tissue culture
Air-exposed tissue culture was performed as previously described [23, 28] . Briefly, biopsies were placed on a collagenous underlayer gel with incorporated irradiated human fibroblasts, which were obtained from retroauricular skin. The explants were cultured in Dulbecco's modified Eagle's medium (DMEM)/Ham's F12 (BioWhittaker, Verviers, Belgium) supplemented with 5% Hyclone fetal calf serum (Greiner, Alphen a/d Rijn, The Netherlands). LPS or LTA was added to the medium in four different final concentrations: 0.01, 1, 100 ng ml À1 and 10 lg ml À1 . LPS was used from Salmonella typhimurium (Sigma, L-6511) and LTA from Staphylococcus aureus (Sigma, L-2525). Cell culture medium was replaced by fresh medium containing LPS and/or LTA every three or four days. After approximately 1 week complete outgrowth of the explants was reached and explants with their outgrowth were cultured for an additional week. After approximately 2 weeks (14-17 days), depending on the speed of outgrow, collagen gels with explant and outgrowth were fixed for light microscopy (LM). A total of 10 different series of experiments were carried out with sphenoid samples from 10 different patients. Each experiment consisted of two controls and two different concentrations of LPS or LTA in duplicate. Bacterial products were added to the culture medium during the entire incubation period to induce chronic morphologic changes to the sinus epithelium.
Histological analysis
For LM, specimens were fixed with a 4% formaldehyde solution for 20 h and subsequently dehydrated through a graded series of ethanol and embedded in paraffin. Sections (4 lm thick) were stained with hematoxylin-eosin (HE) for histological studies and with periodic acid-Schiff (PAS) to determine the presence of mucin glycoconjugates.
Immunohistochemistry
To determine the expression of hCAP-18/LL-37 in cultured sphenoid mucosa, immunohistochemistry was performed on the paraffin sections using the monoclonal anti-LL-37 antibody 3D11 [13] . Paraffin sections were deparaffinized, rehydrated and endogenous peroxidase was quenched using 0.3% H 2 O 2 in methanol for 20 min. Before incubation with the primary antibody the slides were subjected to antigen retrieval (0.01 M citrate buffer, pH 6.0, 10 min) in an autoclave at 120°C and cooled down to room temperature for 2 h. After washing with phosphate-buffered saline (PBS), sections were incubated overnight with the primary anti-LL-37 antibody 3D11 (1.5 lg ml À1 ) in PBS containing 1% bovine serum albumin (BSA), or PBS 1% BSA as negative control. After washing, the slides were incubated for 30 min with a mouse Envision/HRP (DAKO Corporation, Carpinteria, USA) secondary antibody. To visualize immune complexes, the tissues were incubated with a freshly prepared solution of Vector Nova Red (Vector Laboratories, Burlingame) containing 0.01% H 2 O 2 . Mayer's hematoxylin was used to counterstain the sections.
Image analysis
hCAP-18/LL-37 and mucin expression levels were quantified by image analysis (Qwin Ò , Leica Microsystems, The Netherlands). Color image was transformed into a grey image and grey density of the epithelial outgrowth was measured at three different locations (each with an average area of 300 lm 2 ) randomly selected on every epithelial layer (n ¼ 5) of the same culture condition. A grey value of 255 corresponds to white and a density of one to black. Grey values were inverted for graphic representation.
IL-8 ELISA
IL-8 release from the sphenoid was determined in the culture medium. Samples were collected each time the medium was changed and stored at )80°C. IL-8 concentrations were measured using an IL-8 specific ELISA (BioSource International Inc.).
Statistical analysis
Inverted grey values and IL-8 concentrations were expressed as averages AE standard deviation (SD). The differences between the groups were analyzed by oneway ANOVA using the Least Significant Difference as post hoc test (Statistical Package for the Social Sciences, version 10.0 for Windows; SPSS Inc., Chicago, IL). At probability values of p < 0:05, differences were considered statistically significant.
Results
Morphology
Morphological changes of human sphenoid sinus epithelium after incubation with LPS or LTA were described in detail previously [23] . Briefly, sinus mucosa cultured for 2 weeks differentiated from pseudostratified respiratory epithelium to squamous ciliated epithelium with few goblet cells. Incubation with increasing concentrations of LPS or LTA (0.01 ng ml À1 -10 lg ml À1 ) induced increasing amounts of goblet cells and mucus deposits. Microvilli became thick and short, and mucus deposits adhered to the epithelial cell surface, forming a mucus network. The epithelial layer increased in thickness and the epithelial surface became more spherical and irregular. Cilia were absent at high concentrations of LPS or LTA (data not shown). These data indicate that bacterial products induce goblet cell metaplasia in the sinus epithelium.
Expression of hCAP-18/LL-37
hCAP-18/LL-37 expression in sphenoid sinus epithelium cultured for 2 weeks with 0.01 and 1 ng ml À1 LPS or LTA did not significantly differ from control tissues. However, the tissue outgrowth of sphenoid mucosa cultured with 100 ng ml À1 and 10 lg ml À1 LPS or LTA showed a significant increased hCAP-18/LL-37 expression (Fig. 1) . The control tissues without LPS or LTA had an average inverted grey density of 60 AE 10 arbitrary units. The largest response was detected at a concentration of 10 lg ml À1 LTA and was 52% above the control value. Low staining of hCAP-18/LL-37 was visible in the control culture, which was incubated in medium alone (Fig. 2(a) ), whereas the sphenoid tissue cultured with 10 lg ml À1 LPS or LTA (Fig. 2(c) and (e)) showed marked staining for hCAP-18/LL-37. Negative controls showed no staining (data not shown). In gen- eral, hCAP-18/LL-37-positive cells were located at the basal site of the epithelial layer.
Mucin expression
The effects of LPS and LTA on mucin levels in cultured sphenoid tissues were determined by image analysis of PAS-stained sections. Control tissues had an average inverted grey density of 81 AE 17 arbitrary units and showed a low expression (Fig. 2(b) ). LPS or LTA concentrations of 0.01 ng ml À1 (data not shown) did not significantly affect mucin levels in cultured sphenoid tissues as compared with the control after 2 weeks, whereas stimulation with concentrations of 100 ng ml À1 LPS (not shown) or 10 lg ml À1 LTA (Fig. 2(f) ) induced a significant increase in mucin expression. Maximal mucin expression was detected at a concentration of 100 ng ml À1 LPS and was 41% above the control value (Fig. 3) . In contrast to the LL-37 positive cells (Fig. 2(c) and (e)), the PAS-positive cells were mainly located at the apical site of the epithelial layer ( Fig. 2(d) and (f) ). 
Release of IL-8
The effect of LPS and LTA on IL-8 release from cultured sphenoid tissues was determined in cultures stimulated with various concentrations of LPS and LTA at different incubation time points using an IL-8 specific ELISA (Fig. 4) . In control tissue, basal release of IL-8 was detected. LPS (0.1 and 10 lg ml À1 ) significantly increased IL-8 release from day 10-14, while LTA (10 lg ml À1 ) increased IL-8 release significantly from day 14-17.
Discussion
Our results show that both LPS and LTA increase hCAP-18/LL-37 expression in air-exposed cultured sinus epithelium. In addition, LPS and LTA stimulation increased mucin expression and IL-8 release in sinus epithelium. These results suggest that bacterial products may regulate innate immunity by activation of respiratory epithelial cells.
Expression of hCAP-18/LL-37 has been demonstrated to be regulated by various mediators and was suggested to be associated with differentiation. Schauber et al. [29] demonstrated that short chain fatty acids increased LL-37 expression and induced differentiation of colon epithelial cells through different intracellular pathways. Induction of differentiation has been shown to be mediated via the p38 MAPK pathway, while increased LL-37 expression was mediated via the MEK-pathway. Our results show that bacterial products may also affect differentiation of airway epithelium as demonstrated by increased mucin expression, concomitant with increased hCAP-18/LL-37 expression. Furthermore, we show that within the epithelial layer various cell types show increased LL-37 and mucin expression, suggesting that different cellular pathways may be involved in activation of airway epithelium by bacterial products.
Several studies have shown altered hCAP-18/LL-37 expression during infection and inflammation. Expression of hCAP-18/LL-37 at mRNA and protein level was increased in keratinocytes from inflamed skin in psoriasis patients and psoriatic scales were shown to contain hCAP-18/LL-37 [7] . Furthermore, tracheal aspirates derived from mechanically ventilated newborns with pulmonary or systemic infections were demonstrated to contain increased levels of hCAP-18/LL-37 as compared with non-infected newborns [30] . In addition, hCAP-18/ LL-37 augmented in chronic nasal inflammatory disease [31] and in pharyngeal cells LL-37 expression was induced after H. influenzae infection [21] . In contrast, Islam et al. [22] demonstrated that Shigella spp. decreased LL-37 expression in colon epithelial cells both in vitro and in vivo. These bacterial effects on LL-37 expression were suggested to be mediated via bacterial DNA. In this study, we demonstrated that the bacterial products LPS and LTA increase expression of hCAP-18/LL-37 in sinus epithelium. hCAP-18/LL-37 may play a role in host defense by killing bacteria, but may also affect inflammation by recruiting inflammatory cells either directly, or via stimulation of IL-8 release by epithelial cells. Thus, hCAP-18/LL-37 may play an important role in infection and inflammation.
In addition to increasing hCAP-18/LL-37 expression, bacterial products were shown to increase IL-8 release and mucin expression. IL-8 may chemo-attract various inflammatory cells resulting in an inflammatory response and may also activate epithelial cells [32] . Respiratory epithelium stimulated with LPS or LTA has been shown to display a dose-dependent increase in goblet cells as well as an increase in mucus secretion, suggesting that bacterial products may induce mucus cell metaplasia and hypersecretion [23] . Results of animal studies also showed effects of bacterial products on mucus production in the airways. A single and repeated intratracheal instillation of LPS in mouse lungs induced mucus cell metaplasia and hyperplasia [33] , whereas long-term intratracheal LPS instillation in hamsters also resulted in persistent chronic pulmonary inflammation [34, 35] . Increased mucus production and release play important roles in the normal defense mechanism of the respiratory tract by trapping inhaled particles and microbial substances and allowing their removal by mucociliary clearance. Overproduction of mucus, however, contributes to high viscoelasticity and to a stagnant pool of mucus where pathogens can find a niche. This changed mucus, unable to execute its intended clearance function, paradoxically may subsequently nourish support, and protect bacteria from antimicrobial agents. Bacterial products continue to stimulate the epithelial cells and apparently this may be how mucus interacts with bacteria in a vicious cycle leading to irreversible airway obstruction.
What are the mechanisms involved in stimulation of sinus epithelial cells by LPS and LTA? Pattern recognition receptors such as the Toll-like receptors (TLRs) play a central role in the response to microbial products, and respiratory epithelial cells express various TLRs. These receptors may furnish the epithelium with the ability to specifically respond to a certain microbial stimulus. TLR-4 and TLR-2, both expressed on respiratory epithelial cells, have been identified as receptors for LPS and LTA, respectively [36] . Downstream signaling following binding to TLRs involves nuclear translocation of NF-jB [36] , a central transcription factor in the regulation of the cellular response to pathogens. Whereas NF-jB activation has been implicated in the expression of IL-8 [37] , mucins [38] and selected b-defensins [39] , it is not clear whether NF-jB is also involved in the regulation of the expression of hCAP-18/LL-37. In addition, the role of TLRs in chronic changes in the airway mucosa is not clear.
In conclusion, LPS and LTA increase hCAP-18/LL-37 expression in airway epithelial cells. In addition, mucin expression and IL-8 release were increased. This activation of airway epithelial cells may stimulate host defense, but may also result in induction of an inflammatory response.
